XML 53 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCKHOLDERS' DEFICIT (Tables)
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of Assumptions Used to Calculate Fair Value of Options
The following assumptions were used to calculate the fair value of the Successor Company's options on the date of grant:
Year Ended December 31,Period from May 2, 2019 through December 31,
202120202019
Expected volatility56%
44% – 57%
44% – 45%
Expected life in years
6.2 – 6.3
6.0 – 6.3
4.0 – 4.1
Risk-free interest rate
0.79% – 1.15%
0.35% – 1.41%
1.40% – 2.02%
Dividend yield—%—%—%
Schedule of Stock Options Outstanding and Stock Option Activity
The following table presents a summary of the Successor Company's stock options outstanding at and stock option activity during the year ended December 31, 2021 ("Price" reflects the weighted average exercise price per share):
(In thousands, except per share data)OptionsPriceWeighted
Average
Remaining
Contractual Term
Outstanding, January 1, 20217,695 $16.01 5.9 years
Granted296 19.20 
Exercised(244)16.72 
Forfeited(112)13.89 
Expired(20)19.00 
Outstanding, December, 31, 20217,615 16.14 5.1 years
Exercisable3,565 17.52 4.1 years
Expected to Vest4,050 14.93 6.0 years
Summary of Unvested Options and Changes
A summary of the Successor Company's unvested options and changes during the year ended December 31, 2021 is presented below:
(In thousands, except per share data)OptionsWeighted Average Grant Date Fair Value
Unvested, January 1, 20215,491 $5.06 
Granted296 10.28 
Vested (1)
(1,625)5.10 
Forfeited(112)5.00 
Unvested, December 31, 20214,050 5.43 
(1)The total fair value of the options vested during the year ended December 31, 2021 (Successor) was $8.3 million.
Summary of Restricted Stock Outstanding and Restricted Stock Activity
The following table presents a summary of the Successor Company's RSUs outstanding and RSU stock activity as of and during the year ended December 31, 2021 (“Price” reflects the weighted average share price at the date of grant):
(In thousands, except per share data)AwardsPrice
Outstanding, January 1, 20212,578 $14.42 
Granted298 21.57 
Vested (restriction lapsed)(832)14.87 
Forfeited(78)17.41 
Outstanding, December 31, 20211,966 15.20 
The following table presents a summary of the Successor Company's Performance RSUs outstanding and activity as of and during the year ended December 31, 2021 (“Price” reflects the weighted average share price at the date of grant):

(In thousands, except per share data)AwardsPrice
Outstanding, January 1, 2021556 $8.98 
Granted— — 
Vested (restriction lapsed)— — 
Forfeited— — 
Outstanding, December 31, 2021556 $8.98 
Schedule of Stock by Class
Successor Common Stock and Special Warrants
The following table presents the Successor Company's Class A Common Stock, Class B Common Stock and Special Warrants issued and outstanding as of December 31, 2021:
(In thousands, except share and per share data)December 31,
2021
Successor Class A Common Stock, par value $.001 per share, 1,000,000,000 shares authorized
120,633,937 
Successor Class B Common Stock, par value $.001 per share, 1,000,000,000 shares authorized
21,590,192 
Successor Special Warrants5,304,430 
  Total Successor Class A Common Stock, Class B Common Stock and Special Warrants issued and outstanding147,528,559 
Schedule of Loss Per Share
(In thousands, except per share data)Successor CompanyPredecessor Company
Year Ended December 31,Period from May 2, 2019 through December 31,Period from January 1, 2019 through May 1,
 2021202020192019
NUMERATOR: 
Net income (loss) attributable to the Company – common shares$(159,199)$(1,914,699)$112,548 $11,184,141 
Exclude:
  Income from discontinued operations, net of tax$— $— $— $1,685,123 
  Noncontrolling interest from discontinued operations, net of tax - common shares
— — 19,028 
Total income from discontinued operations, net of tax - common shares$— $— $— $1,704,151 
Total income (loss) from continuing operations$(159,199)$(1,914,699)$112,548 $9,479,990 
  Noncontrolling interest from continuing operations, net of tax - common shares
(810)523 (751)— 
Income (loss) from continuing operations$(158,389)$(1,915,222)$113,299 $9,479,990 
DENOMINATOR(1):
 
Weighted average common shares outstanding - basic146,726 145,979 145,608 86,241 
  Stock options and restricted stock(2):
— — 187 — 
Weighted average common shares outstanding - diluted146,726 145,979 145,795 86,241 
Net income (loss) attributable to the Company per common share: 
From continuing operations - Basic$(1.09)$(13.12)$0.77 $109.92 
From discontinued operations - Basic$— $— $— $19.76 
From continuing operations - Diluted$(1.09)$(13.12)$0.77 $109.92 
From discontinued operations - Diluted$— $— $— $19.76 

(1)All of the outstanding Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Successor Company for the year ended December 31, 2021, December 31, 2020 and the period from May 2, 2019 through December 31, 2019.
(2)Outstanding equity awards representing 10.5 million, 9.1 million and 5.9 million shares of Class A common stock of the Successor Company for the year ended December 31, 2021, the year ended December 31, 2020, and the period from May 2, 2019 through December 31, 2019, respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive. Outstanding equity awards representing 5.9 million shares of Class A common stock of the Predecessor Company for the period for the period from January 1, 2019 through May 1, 2019 were not included in the computation of diluted earnings per share because to do so would have been antidilutive.